| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | 0.082 | 0.03 |
| mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.03 |
| mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.03 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | 0.066 | 0.03 |
| mRNA | AM-580 | CTRPv2 | pan-cancer | AAC | 0.077 | 0.03 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | 0.071 | 0.04 |
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.072 | 0.04 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.11 | 0.04 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | -0.061 | 0.04 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | 0.067 | 0.04 |